Skip to main content

Table 1 Clinical phenotypes and polymorphisms in migraine-related genes (SCN1A, CACNA1A, ATP1A2, KCNK18) in the study group

From: Genetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genes

ID

Year of birth

Sex

Clinical phenotype

SCN1A, CACNA1A, ATP1A2, KCNK18

1

1980

M

MA

 

2

1976

F

F?HM

c.4498A>G, p.M1500V, rs376885324 (ex. 24 SCN1A)

3

1978

F

MA

rs2298771 (ex. 16 SCN1A)

4a

1952

F

FHM

rs17846715 (ex. 16 ATP1A2)

4b

1978

F

FHM

 

4c

1980

F

FHM

 

5

1967

F

MO

 

6

1967

F

MO

 

7a

1954

M

FHM + EPI

 

7b

1982

M

FHM + EPI

rs2298771 (ex. 16 SCN1A), rs16012 (ex. 13 CACNA1A)

7c

1984

M

MO

rs2298771 (ex. 16 SCN1A)

8

1980

M

SHM

 

9

1958

F

F?HM

 

10

1944

F

MO

Novel intronic polymorphism c.4581 + 32A>G, between ex. 24 and 25

11

1946

F

MO

 

12

1954

F

MO

 

13

1982

F

MA

 

14

1966

F

MO

rs2298771 (ex. 16 SCN1A)

15

1962

M

MO

 

16

1972

F

MA

c.691T>C, p.S231P, rs363315 (ex. 3 KCNK18), rs16016 (ex. 16 CACNA1A)

17

1962

M

MO

 

18

1968

F

MO

 

19

1943

F

MO

rs2298771 (ex. 16 SCN1A)

20

1963

F

F?HM

rs41288127, rs55884181 (ex. 22 ATP1A2)

21

1957

F

F?HM

 

22

1978

F

MO

rs2298771 (ex. 16 SCN1A)

23

1968

F

MA

rs2298771 (ex. 16 SCN1A)

24

1934

F

MO

rs2298771 (ex. 16 SCN1A)

25

1960

F

MO

 

26

1953

F

MA

rs16012 (ex. 13 CACNA1A)

27

1973

F

SHM

rs41276894 (ex. 4 CACNA1A)

28

1977

F

F?HM

 

29

1988

M

SHM + MR

 

30

1969

F

F?HM

rs61734524 (ex. 9 ATP1A2)

31

1973

F

SHM

rs17846715 (ex. 16 ATP1A2)

32

1976

M

MO

rs2298771 (ex. 16 SCN1A)

33

1987

F

SHM

rs17846715 (ex. 16 ATP1A2), rs41288127 (ex. 22 ATP1A2)

34

1970

F

MO

rs2298771 (ex. 16 SCN1A)

35

1972

F

MO

 

36

1968

F

MO

 

37

1966

F

MA

rs2298771 (ex. 16 SCN1A)

38

1969

F

MA

 

39a

1988

F

MO

 

39b

1960

F

MO

 

40

1970

F

MO

 

41

1974

F

MO

 

42

1958

F

MO

 

43a

1989

M

MO (mutation in Leiden factor V)

rs61734524 (ex.9 ATP1A2), rs16016 (ex. 16 CACNA1A)

43b

1994

F

FHM (mutation in factor V Leiden)

rs61734524 (ex.9 ATP1A2)

43c

1970

F

FHM (mutation in factor V Leiden)

rs61734524 (ex.9 ATP1A2), rs16016 (ex. 16 CACNA1A)

43d

1950

M

Ischemic stroke (mutation in factor V Leiden), mother with FHM + MA

 

44

1958

F

MO + EA

 

45

1960

F

MA

 

46a

1943

F

SHM mother

rs61734524 (ex. 9 ATP1A2)

46b

1984

M

SHM

Not tested

46c

1943

M

SHM father

 

47

1962

F

MA

rs17846715 (ex. 16 ATP1A2)

48

1967

M

SHM

 

49

1963

F

MA

 

50

1972

F

SHM

rs61734524 (ex. 9 ATP1A2), rs17846715 (ex. 16 ATP1A2)

51

1959

F

MA

rs2298771 (ex. 16 SCN1A)

  1. Description of clinical phenotype: EA, episodic ataxia, Epi epileptic seizures, F?HM probable familial hemiplegic migraine, FHM familial hemiplegic migraine, MA migraine with typical aura, MO migraine without aura, MR mental retardation, SHM sporadic hemiplegic migraine